Santo Therapeutics

Private

HangzhouHealthcare & Life Scienceshttps://santobiopharma.com/

Last Round

Angel

Sep 28, 2025

Company Overview

Santo Therapeutics is a biotechnology company that develops next-generation lentiviral vector gene therapies for cancer and rare genetic disorders.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Infrastructure

Keywords

in vivo gene therapylentiviral vectorgene therapybiotechdrug discoveryoncologyrare genetic diseasebiomanufacturingprecision medicineprocess optimizationclinical stage biotechvector designgenomic medicinecell and gene therapybiopharma

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Santo Therapeutics Comparables

Compare Santo Therapeutics with similar companies based on industry and business-model similarity.

Santo Therapeutics comparables — related companies by embedding similarity
Company	Similarity	Market Cap
Abintus Bio	81%
NF2 Therapeutics, Inc.	77%
Vyriad	75%

View all Comparables

Santo Therapeutics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Angel	Sep 28, 2025
Angel	Dec 29, 2023

View all Funding Rounds

Santo Therapeutics Investors

Notable investors and investment history

Santo Therapeutics investors
Investor	Rounds
Triwise Capital	Angel
Transfar Capital	Angel

View all Investors

Santo Therapeutics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Santo Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Santo Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersHangzhou

Employee Range5

Year Founded2020

Last FundingSep 28, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?